In the BioHarmony Drug Report Database

"Preview" Icon

Temozolomide

Temodar, Temodal (temozolomide) is a small molecule pharmaceutical. Temozolomide was first approved as Temodar on 1999-01-26. It is used to treat glioblastoma and melanoma in the USA. It has been approved in Europe to treat glioblastoma and glioma. Temodal’s patent is valid until 2023-09-08 (FDA).

 

Trade Name

 

Temodal
 

Common Name

 

temozolomide
 

ChEMBL ID

 

CHEMBL810
 

Indication

 

glioblastoma, glioma, melanoma
 

Drug Class

 

Image (chem structure or protein)

Temozolomide structure rendering